NICE Claims Botox Migraine Treatment Efficiency Uncertain
Media sources reported that the British National Institute for Health and Clinical Excellence (NICE) stated that there is insufficient evidence to support using Botox in the treatment of chronic migraines.
Migraines are classified as severe headaches, often resulting in nausea, vomiting and sensitivity to light and sound. Chronic migraines are characterized by having at least 15 headaches a month, with 8 of them being migraines.
Botox was approved for use in the treatment of chronic migraines in mid-2010 in the UK. The treatment involves injecting the drug into roughly 30 different sites around the head and neck at 12-week intervals. However, it is still unclear how this therapy is beneficial in the prevention of chronic migraines. It is though to block overactive nerve impulses that trigger excessive muscle contractions, but this inconclusive.
NICE is in the process of deciding whether the treatment should be offered across the UK. The agency has stated that the therapy has “shown some benefit”, but that he effects were small and may have been confused by the way the data was gathered.
As a West Los Angeles migraine doctor, I’m always searching for new ways to aid in alleviating my patients’ pain symptoms. If you suffer from a chronic condition that results in pain, speak with a West Los Angeles pain management doctor to discuss the treatments that may be able to help you.